Exosomal lncRNAs in gastrointestinal cancer

Clin Chim Acta. 2023 Feb 1:540:117216. doi: 10.1016/j.cca.2022.117216. Epub 2022 Dec 30.

Abstract

Gastrointestinal cancer (GIC) remains a leading cause of morbidity and mortality worldwide. Unfortunately, these cancers are diagnosed in advanced metastatic stages due to lack of reliable biomarkers that are sufficiently specific and sensitive in early disease. There has been growing evidence that circulating exosomes can be used to diagnose cancer non-invasively with limited risks and side effects. Furthermore, exosomal long non-coding RNAs (lncRNAs) are emerging as a new class of promising biomarkers in cancer. This review provides an overview of the extraction and detection of exosomal lncRNAs with a focus on their potential role in GIC.

Keywords: Biomarker; Diagnosis; Exosomes; Gastrointestinal cancers; Long non-coding RNA.

Publication types

  • Review

MeSH terms

  • Biomarkers, Tumor / genetics
  • Exosomes* / genetics
  • Gastrointestinal Neoplasms* / diagnosis
  • Gastrointestinal Neoplasms* / genetics
  • Gene Expression Regulation, Neoplastic
  • Humans
  • RNA, Long Noncoding* / genetics

Substances

  • RNA, Long Noncoding
  • Biomarkers, Tumor